ABSTRACT
Failure of palatogenesis results in cleft palate, one of the most common congenital disabilities in humans. During the final phases of palatogenesis, the protective function of the peridermal cell layer must be eliminated for the medial edge epithelia to adhere properly, which is a prerequisite for the successful fusion of the secondary palate. However, a deeper understanding of the role and fate of the periderm in palatal adherence and fusion has been hampered due to a lack of appropriate periderm-specific genetic tools to examine this cell type in vivo. Here we used the cytokeratin-6A (Krt-6a) locus to develop both constitutive (Krt6ai-Cre) and inducible (Krt6ai-CreERT2) periderm-specific Cre driver mouse lines. These novel lines allowed us to achieve both the spatial and temporal control needed to dissect the periderm fate on a cellular resolution during palatogenesis. Our studies suggest that, already before the opposing palatal shelves contact each other, at least some palatal periderm cells start to gradually lose their squamous periderm-like phenotype and dedifferentiate into cuboidal cells, reminiscent of the basal epithelial cells seen in the palatal midline seam. Moreover, we show that transforming growth factor-ß (TGF-ß) signaling plays a critical periderm-specific role in palatogenesis. Thirty-three percent of embryos lacking a gene encoding the TGF-ß type I receptor (Tgfbr1) in the periderm display a complete cleft of the secondary palate. Our subsequent experiments demonstrated that Tgfbr1-deficient periderm fails to undergo appropriate dedifferentiation. These studies define the periderm cell fate during palatogenesis and reveal a novel, critical role for TGF-ß signaling in periderm dedifferentiation, which is a prerequisite for appropriate palatal epithelial adhesion and fusion.
Subject(s)
Cleft Palate , Palate , Transforming Growth Factor beta , Animals , Humans , Mice , Cleft Palate/genetics , Epithelial Cells/metabolism , Palate/growth & development , Palate/metabolism , Receptor, Transforming Growth Factor-beta Type I/metabolism , Transforming Growth Factor beta/metabolismABSTRACT
Clefting of the secondary palate is one of the most common congenital anomalies, and the multiple corrective surgeries that individuals with isolated cleft palate undergo are associated with major costs and morbidities. Secondary palate development is a complex, multistep process that includes the elevation of the palatal shelves from a vertical to horizontal position, a process that is not well understood. The Hippo signaling cascade is a mechanosensory pathway that regulates morphogenesis, homeostasis, and regeneration by controlling cell proliferation, apoptosis, and differentiation, primarily via negative regulation of the downstream effectors, Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). We deleted Yap/Taz throughout the palatal shelf mesenchyme as well as specifically in the posterior palatal shelf mesenchyme, using the Osr2Cre and Col2Cre drivers, respectively, which resulted in palatal shelf elevation delay and clefting of the secondary palate. In addition, the deletion resulted in undersized bones of the secondary palate. We next determined downstream targets of YAP/TAZ in the posterior palatal shelves, which included Ibsp and Phex, genes involved in mineralization, and Loxl4, which encodes a lysyl oxidase that catalyzes collagen crosslinking. Ibsp, Phex, and Loxl4 were expressed at decreased levels in the ossification region in the posterior palatal shelf mesenchyme upon deletion of Yap/Taz. Furthermore, collagen levels were decreased specifically in the same region prior to elevation. Thus, our data suggest that YAP/TAZ may regulate collagen crosslinking in the palatal shelf mesenchyme, thus controlling palatal shelf elevation, as well as mineralization of the bones of the secondary palate.
Subject(s)
Cleft Palate , Palate , Animals , Cleft Palate/genetics , Gene Expression Regulation, Developmental , Mice , Morphogenesis , OsteogenesisABSTRACT
In many physical processes, including cloud electrification, electrospray, and demulsification, droplets and bubbles are exposed to electric fields and may either remain whole or burst in response to electrical stresses. Determining the stability limit of a droplet exposed to an external electric field has been a long-standing mathematical challenge, and the only analytical treatment to date is an approximate calculation for the particular case of a free-floating droplet. Here we demonstrate, experimentally and theoretically, that the stability limit of a conducting droplet or bubble exposed to an external electric field is described by a power law with broad generality that, in practice, applies to the cases in which the droplet or bubble is pinned or sliding on a conducting surface or free floating. This power law can facilitate the design of devices for liquid manipulation via a simple formula that captures the parameter range of bubbles and droplets that can be supported on electrified surfaces.
ABSTRACT
Millimetric droplets may be levitated on the surface of a vibrating fluid bath. Eddi et al. [Europhys. Lett. 82, 44001 (2008)] demonstrated that when a pair of levitating drops of unequal size are placed nearby, they interact through their common wavefield in such a way as to self-propel through a ratcheting mechanism. We present the results of an integrated experimental and theoretical investigation of such ratcheting pairs. Particular attention is given to characterizing the dependence of the ratcheting behavior on the droplet sizes and vibrational acceleration. Our experiments demonstrate that the quantized inter-drop distances of a ratcheting pair depend on the vibrational acceleration, and that as this acceleration is increased progressively, the direction of the ratcheting motion may reverse up to four times. Our simulations highlight the critical role of both the vertical bouncing dynamics of the individual drops and the traveling wave fronts generated during impact on the ratcheting motion, allowing us to rationalize the majority of our experimental findings.
ABSTRACT
We present the results of an experimental investigation of the dynamics of droplets bouncing on a vibrating fluid bath for forcing accelerations above the Faraday threshold. Two distinct fluid viscosity and vibrational frequency combinations (20 cS-80 Hz and 50 cS-50 Hz) are considered, and the dependence of the system behavior on drop size and vibrational acceleration is characterized. A number of new dynamical regimes are reported, including meandering, zig-zagging, erratic bouncing, coalescing, and trapped regimes. Particular attention is given to the regime in which droplets change direction erratically and exhibit a dynamics akin to Brownian motion. We demonstrate that the effective diffusivity increases with vibrational acceleration and decreases with drop size, as suggested by simple scaling arguments.
ABSTRACT
The walking droplet system has extended the range of classical systems to include several features previously thought to be exclusive to quantum systems. We review the hierarchy of analytic models that have been developed, on the basis of various simplifying assumptions, to describe droplets walking on a vibrating fluid bath. Particular attention is given to detailing their successes and failures in various settings. Finally, we present a theoretical model that may be adopted to explore a more generalized pilot-wave framework capable of further extending the phenomenological range of classical pilot-wave systems beyond that achievable in the laboratory.
ABSTRACT
The application of massively parallel sequencing (MPS) is growing in the forensic DNA field, as forensic DNA laboratories are continuously seeking methods to gain information from a limited or degraded forensic sample. However, the laborious nature of current MPS methodologies required for successful library preparation and sequencing leave opportunities for improvement to make MPS a practical option for processing forensic casework. In this study, the Promega PowerSeq™ Auto/Y System Prototype, a MPS laboratory workflow that incorporates multiplex amplification, was selected for optimization with the objectives to introduce automation for relieving manual processing, and to reduce the number of steps recommended by the standard protocol. Successful changes in the optimized workflow included a switch from column-based PCR purification to automatable bead-based purification, adoption of the library preparation procedures by a liquid handling robot platform, and removal of various time-consuming quality checks. All data in this study were found to be concordant with capillary electrophoresis (CE) data and previously-generated MPS results from this workflow. Read abundance and allele balance, metrics related to sample interpretation reliability, were not significantly different when compared to samples processed with the manufacturer's protocol. All the modifications implemented resulted in increased laboratory efficiency, reduced the protocol steps associated with risk of contamination and human error events, and decreased manual processing time by approximately 12h. These findings provide forensic DNA laboratories a more streamlined option when considering implementation of a MPS workflow.
Subject(s)
Efficiency, Organizational , Electronic Data Processing , High-Throughput Nucleotide Sequencing/instrumentation , Laboratories , Sequence Analysis, DNA , Workflow , Amelogenin/genetics , Chromosomes, Human, Y , Genetic Markers , High-Throughput Nucleotide Sequencing/methods , Humans , Microsatellite RepeatsABSTRACT
BACKGROUND: Anecdotally, aloe vera is used to treat gastric ulceration, although no studies have yet investigated its efficacy in horses. OBJECTIVES: To test the hypothesis that aloe vera would be noninferior to omeprazole in the treatment of equine gastric ulcer syndrome. STUDY DESIGN: Randomised, blinded clinical trial. METHODS: Forty horses with grade ≥2 lesions of the squamous and/or glandular mucosa were randomly assigned to one of two groups. Horses received either aloe vera inner leaf gel (17.6 mg/kg bwt) b.i.d. or omeprazole (4 mg/kg bwt) s.i.d. for approximately 28 days, after which a repeat gastroscopic examination was performed to determine disease resolution. Horses with persistent lesions were offered a further 28 days of treatment with omeprazole (4 mg/kg bwt s.i.d.) and were re-examined on completion of treatment. RESULTS: Efficacy analyses were based on 39 horses that completed the trial. Equine squamous gastric disease (ESGD) was observed in 38 horses; improvement and healing rates in these horses were 56% and 17%, respectively, in the aloe vera group, and 85% and 75%, respectively, in the omeprazole group. Healing was less likely to occur in horses with prolonged gastric emptying. Equine glandular gastric disease (EGGD) was less common than ESGD (n = 14) and numbers were too small to perform meaningful statistical analyses. The hypothesis that aloe vera would be noninferior to omeprazole was not supported. MAIN LIMITATIONS: No placebo control group was included. Limited numbers preclude any comment on the efficacy of aloe vera in the treatment of EGGD. CONCLUSIONS: Treatment with aloe vera was inferior to treatment with omeprazole.
Subject(s)
Aloe , Horse Diseases/drug therapy , Omeprazole/therapeutic use , Stomach Ulcer/veterinary , Animals , Female , Gels , Horses , Male , Omeprazole/administration & dosage , Phytotherapy , Stomach Ulcer/drug therapyABSTRACT
We present the results of a theoretical investigation of the dynamics of a droplet walking on a vibrating fluid bath under the influence of a harmonic potential. The walking droplet's horizontal motion is described by an integro-differential trajectory equation, which is found to admit steady orbital solutions. Predictions for the dependence of the orbital radius and frequency on the strength of the radial harmonic force field agree favorably with experimental data. The orbital quantization is rationalized through an analysis of the orbital solutions. The predicted dependence of the orbital stability on system parameters is compared with experimental data and the limitations of the model are discussed.
ABSTRACT
BACKGROUND: Common variable immunodeficiency (CVID) is characterized by late-onset hypogammaglobulinemia in the absence of predisposing factors. The genetic cause is unknown in the majority of cases, and less than 10% of patients have a family history of the disease. Most patients have normal numbers of B cells but lack plasma cells. METHODS: We used whole-exome sequencing and array-based comparative genomic hybridization to evaluate a subset of patients with CVID and low B-cell numbers. Mutant proteins were analyzed for DNA binding with the use of an electrophoretic mobility-shift assay (EMSA) and confocal microscopy. Flow cytometry was used to analyze peripheral-blood lymphocytes and bone marrow aspirates. RESULTS: Six different heterozygous mutations in IKZF1, the gene encoding the transcription factor IKAROS, were identified in 29 persons from six families. In two families, the mutation was a de novo event in the proband. All the mutations, four amino acid substitutions, an intragenic deletion, and a 4.7-Mb multigene deletion involved the DNA-binding domain of IKAROS. The proteins bearing missense mutations failed to bind target DNA sequences on EMSA and confocal microscopy; however, they did not inhibit the binding of wild-type IKAROS. Studies in family members showed progressive loss of B cells and serum immunoglobulins. Bone marrow aspirates in two patients had markedly decreased early B-cell precursors, but plasma cells were present. Acute lymphoblastic leukemia developed in 2 of the 29 patients. CONCLUSIONS: Heterozygous mutations in the transcription factor IKAROS caused an autosomal dominant form of CVID that is associated with a striking decrease in B-cell numbers. (Funded by the National Institutes of Health and others.).
Subject(s)
B-Lymphocytes , Common Variable Immunodeficiency/genetics , Ikaros Transcription Factor/genetics , Mutation , Adolescent , Adult , Antigens, CD/analysis , Bone Marrow/immunology , Bone Marrow Examination , Child , Child, Preschool , Chromosomes, Human, Pair 7 , Common Variable Immunodeficiency/immunology , Exome , Female , Heterozygote , Humans , Immunoglobulin G/blood , Lymphocyte Count , Male , Pedigree , Sequence Analysis, DNA/methodsABSTRACT
Coughs and sneezes feature turbulent, multiphase flows that may contain pathogen-bearing droplets of mucosalivary fluid. As such, they can contribute to the spread of numerous infectious diseases, including influenza and SARS. The range of contamination of the droplets is largely determined by their size. However, major uncertainties on the drop size distributions persist. Here, we report direct observation of the physical mechanisms of droplet formation at the exit of the mouth during sneezing. Specifically, we use high-speed imaging to directly examine the fluid fragmentation at the exit of the mouths of healthy subjects. We reveal for the first time that the breakup of the fluid into droplets continues to occur outside of the respiratory tract during violent exhalations. We show that such breakup involves a complex cascade of events from sheets, to bag bursts, to ligaments, which finally break into droplets. Finally, we reveal that the viscoelasticity of the mucosalivary fluid plays an important role in delaying fragmentation by causing the merger of the droplet precursors that form along stretched filaments; thereby affecting the final drop size distribution farther downstream.
ABSTRACT
We report the results of a theoretical investigation of the stability of a toroidal vortex bound by an interface. Two distinct instability mechanisms are identified that rely on, respectively, surface tension and fluid inertia, either of which may prompt the transformation from a circular to a polygonal torus. Our results are discussed in the context of three experiments, a toroidal vortex ring, the hydraulic jump, and the hydraulic bump.
Subject(s)
Achondroplasia/drug therapy , Achondroplasia/pathology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Receptor, Fibroblast Growth Factor, Type 3/deficiency , Receptor, Fibroblast Growth Factor, Type 3/genetics , Thanatophoric Dysplasia/drug therapy , Thanatophoric Dysplasia/pathology , Animals , Female , MaleABSTRACT
This study aimed to assess the effectiveness of a novel, community-based weight management programme delivered through general practitioner (GP) practices and community pharmacies in one city in the United Kingdom. This study used a non-randomized, retrospective, observational comparison of clinical data collected by participating GP practices and community pharmacies. Subjects were 451 overweight or obese men and women resident in areas of high socioeconomic deprivation (82% from black and minority ethnic groups, 86% women, mean age: 41.1 years, mean body mass index [BMI]: 34.5 kg m(-2)). Weight, waist circumference and BMI at baseline, after 12 weeks and after 9 months were measured. Costs of delivery were also analysed. Sixty-four per cent of participants lost weight after the first 12 weeks of the My Choice Weight Management Programme. There was considerable dropout. Mean percentage weight loss (last observation carried forward) was 1.9% at 12 weeks and 1.9% at final follow-up (9 months). There was no significant difference in weight loss between participants attending GP practices and those attending pharmacies at both 12 weeks and at final follow-up. Costs per participant were higher via community pharmacy which was attributable to better attendance at sessions among community pharmacy participants than among GP participants. The My Choice Weight Management Programme produced modest reductions in weight at 12 weeks and 9 months. Such programmes may not be sufficient to tackle the obesity epidemic.
Subject(s)
Community Pharmacy Services/organization & administration , Obesity/therapy , Primary Health Care/organization & administration , Weight Reduction Programs , Adult , Community Pharmacy Services/economics , Female , Humans , Male , Middle Aged , Obesity/epidemiology , Primary Health Care/economics , United Kingdom/epidemiology , Weight LossABSTRACT
Glycogen synthase kinase 3 ß (GSK-3ß) is an essential negative regulator or "brake" on many anabolic-signaling pathways including Wnt and insulin. Global deletion of GSK-3ß results in perinatal lethality and various skeletal defects. The goal of our research was to determine GSK-3ß cell-autonomous effects and postnatal roles in the skeleton. We used the 3.6-kb Col1a1 promoter to inactivate the Gsk3b gene (Col1a1-Gsk3b knockout) in skeletal cells. Mutant mice exhibit decreased body fat and postnatal bone growth, as well as delayed development of several skeletal elements. Surprisingly, the mutant mice display decreased circulating glucose and insulin levels despite normal expression of GSK-3ß in metabolic tissues. We showed that these effects are due to an increase in global insulin sensitivity. Most of the male mutant mice died after weaning. Prior to death, blood glucose changed from low to high, suggesting a possible switch from insulin sensitivity to resistance. These male mice die with extremely large bladders that are preceded by damage to the urogenital tract, defects that are also seen type 2 diabetes. Our data suggest that skeletal-specific deletion of GSK-3ß affects global metabolism and sensitizes male mice to developing type 2 diabetes.
Subject(s)
Bone Development , Bone and Bones/enzymology , Diabetes Mellitus, Type 2/complications , Energy Metabolism , Glycogen Synthase Kinase 3/metabolism , Insulin Resistance , Male Urogenital Diseases/complications , Animals , Bone and Bones/metabolism , Bone and Bones/pathology , Collagen Type I/genetics , Collagen Type I/metabolism , Collagen Type I, alpha 1 Chain , Crosses, Genetic , Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/metabolism , Diabetes Mellitus, Type 2/pathology , Disease Susceptibility , Female , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3 beta , Male , Mice , Mice, Knockout , Mice, Mutant Strains , Mice, Transgenic , Promoter Regions, Genetic , Sex Characteristics , Survival Analysis , Urogenital System/pathology , WeaningABSTRACT
Unlike seminomas in humans, seminomas in animals are not typically sub-classified as classical or spermatocytic types. To compare testicular germ cell tumours (TGCT) in dogs with those of men, archived tissues from 347 cases of canine testicular tumours were morphologically evaluated and characterized using human classification criteria. Histopathological and immunohistological analysis of PLAP, KIT, DAZ and DMRT1 expression revealed that canine seminomas closely resemble human spermatocytic seminomas. In addition, a relatively frequent concomitant presence of somatic cell tumours was noted in canine TGCT. None of the canine TGCT evaluated demonstrated the presence of carcinoma in situ cells, a standard feature of human classical seminomas, suggesting that classical seminomas either do not occur in dogs or are rare in occurrence. Canine spermatocytic seminomas may provide a useful model for this rare human neoplasm.
Subject(s)
Neoplasms, Germ Cell and Embryonal/veterinary , Seminoma/veterinary , Testicular Neoplasms/veterinary , Animals , Deleted in Azoospermia 1 Protein , Dogs , Extracellular Matrix Proteins/biosynthesis , Humans , Male , Neoplasms, Germ Cell and Embryonal/metabolism , Neoplasms, Germ Cell and Embryonal/pathology , Proto-Oncogene Proteins c-kit/biosynthesis , RNA-Binding Proteins/biosynthesis , Seminoma/metabolism , Seminoma/pathology , Testicular Neoplasms/metabolism , Testicular Neoplasms/pathology , Transcription Factors/biosynthesisABSTRACT
BACKGROUND: Scarring is a major problem following skin injury. In early clinical trials, transforming growth factor ß3 (avotermin) improved scar appearance. The aim of this study was to determine whether an injection of avotermin at the time of wound closure is effective in improving scar appearance. METHODS: Study RN1001-0042, a double-blind, randomized, within-patient, placebo-controlled trial, investigated the efficacy and safety of four doses of avotermin given once. Patients undergoing bilateral surgery to remove varicose leg veins by saphenofemoral ligation and long saphenous vein stripping were enrolled at 20 European centres. A total of 156 patients were randomized to receive one of four doses of avotermin (5, 50, 200 or 500 ng per 100 µl, at 100 µl per linear cm of wound margin), administered by intradermal injection to the groin and distal wound margins of one leg; placebo was administered to the other leg. Scar appearance was evaluated by an independent panel of lay people (lay panel), investigators and patients. The primary efficacy variable was lay panel Total Scar Score (ToScar), derived from visual analogue scale scores for groin scars between 6 weeks and 7 months. RESULTS: Avotermin 500 ng significantly improved groin scar appearance compared with placebo (mean lay panel ToScar difference 16·49 mm; P = 0·036). CONCLUSION: Avotermin 500 ng per 100 µl per linear cm of wound margin given once is well tolerated and significantly improves scar appearance.
Subject(s)
Cicatrix/drug therapy , Dermatologic Agents/administration & dosage , Groin/surgery , Transforming Growth Factor beta3/administration & dosage , Adult , Aged , Aged, 80 and over , Double-Blind Method , Female , Humans , Injections, Intradermal , Male , Middle Aged , Prospective Studies , Surgicenters , Treatment Outcome , Varicose Veins/surgery , Young AdultABSTRACT
We present the results of a combined experimental and theoretical investigation of rolling elastic ribbons. Particular attention is given to characterizing the steady shapes that arise in static and dynamic rolling configurations. In both cases, above a critical value of the forcing (either gravitational or centrifugal), the ribbon assumes a two-lobed, peanut shape similar to that assumed by rolling droplets. Our theoretical model allows us to rationalize the observed shapes through consideration of the ribbon's bending and stretching in response to the applied forcing.
ABSTRACT
Chondromyxoid fibroma is a benign yet highly recurrent neoplasm of bone, usually found in the metaphyseal segments of long bones. We present the case of an unusual diaphyseal chondromyxoid fibroma of the radius and review the literature regarding these rare chondroid neoplasms.
Subject(s)
Bone Neoplasms/pathology , Bone Transplantation/methods , Chondroblastoma/pathology , Fibroma/pathology , Radius/pathology , Adult , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/surgery , Chondroblastoma/diagnostic imaging , Chondroblastoma/surgery , Fibroma/diagnostic imaging , Fibroma/surgery , Fibula/transplantation , Humans , Male , Neoplasms, Multiple Primary , Radiography , Radius/diagnostic imaging , Radius/physiopathology , Radius/surgery , Range of Motion, Articular , Recovery of FunctionABSTRACT
Gas release in photic-zone microbialites can lead to preservable morphological biosignatures. Here, we investigate the formation and stability of oxygen-rich bubbles enmeshed by filamentous cyanobacteria. Sub-millimetric and millimetric bubbles can be stable for weeks and even months. During this time, lithifying organic-rich laminae surrounding the bubbles can preserve the shape of bubbles. Cm-scale unstable bubbles support the growth of centimetric tubular towers with distinctly laminated mineralized walls. In environments that enable high photosynthetic rates, only small stable bubbles will be enclosed by a dense microbial mesh, while in deep waters extensive microbial mesh will cover even larger photosynthetic bubbles, increasing their preservation potential. Stable photosynthetic bubbles may be preserved as sub-millimeter and millimeter-diameter features with nearly circular cross-sections in the crests of some Proterozoic conical stromatolites, while centrimetric tubes formed around unstable bubbles provide a model for the formation of tubular carbonate microbialites that are not markedly depleted in (13)C.